In the late 18th century, Edward Jenner, an English physician and scientist overheard a milkmaid say ”I shall never have smallpox for I have had cowpox. I shall never have an ugly pockmarked face.” This had helped him understand that the cowpox virus countered the smallpox virus, and thus, the first human vaccine was born.
What is a Vaccine?
A vaccine is a biological preparation that helps the human body develop immunity to a particular disease. Vaccines are generally prepared from weakened or dead microbes that can cause a particular disease in their healthy state. Vaccines make our body immune to numerous diseases such as polio, chickenpox, influenza, cancer, and infections such as hepatitis A and hepatitis B, tetanus, and bacillus aureus.
Why is the Global Human Vaccine Market Rising?
Emerging technologies and increased awareness among people (mainly due to government and non-government campaigns) are some of the factors that are responsible for the rapid growth of the Global Human Vaccine Market. The development of novel therapeutic vaccines to combat diseases such as cancer and HIV/AIDS further complement the growth of the market. The emergence of several pharmaceutical manufacturers is indicative of the profit potential of this market.
The Americas dominate the Global Human Vaccine Market with a 50 percent of the global market share. The APAC region is not far behind and has witnessed tremendous growth in the past few years because of the growing public demand for regular and pediatric immunization vaccines. Worldwide, with improving economic conditions, people across the globe are in a stronger financial position to afford better medical treatment. As a result, the Global Human Vaccine Market is poised to grow at a rapid pace with a CAGR of around 17 percent over the period 2011-2015.
After all, prevention, they say, is always better than cure.
Technavio’s related reports
Global Human Vaccines Market 2011-2015
Global Vaccine Market 2010-2014
